A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction-Reference-Cited by-同舟云学术

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

Published:2010-09 Issue:8 Volume:28 Page:833-838
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Malik Imtiaz,Bernal Pedro,Byrd Janet

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357901003630942

Reference37 articles.

1. Alexander, H.R.; Kelsen, D.P.; Tepper, J.E. Cancer of the stomach. In Cancer: Principles and Practice of Oncology, V.T. DeVita, S. Hellman, S.A. Rosenberg (eds). Philadelphia, PA: Lppincott-Raven, 1997, 1021–1054.

2. Evolving Chemotherapy for Advanced Gastric Cancer

3. Medical treatment for advanced gastroesophageal adenocarcinoma

4. Chemotherapy for metastatic gastric cancer: past, present, and future

5. Gastric cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial;Gastric Cancer;2022-03-30

2. Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction;Cancer Chemotherapy and Pharmacology;2015-10-23

3. Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients;International Journal of Clinical Oncology;2012-06-05

4. Capecitabine in gastric cancer;Expert Review of Anticancer Therapy;2011-12

5. Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma;World Journal of Gastroenterology;2011